Dr. Ananda Wijewickrama has been appointed as the new chairman of the National Medicines Regulatory Authority (NMRA). The Minister of Health and Industries Dr. Ramesh Pathirana announced the ...

The idea that more choice is better is baked into Western culture, but research shows that having more options can make ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Neumora Therapeutics projected cash runway "into 2027" tied to clinical milestones that never materialized -- then cut 35% of its workforce the same day both pivotal trials failed. During the Q2 2025 ...

PRINCETON – At least two people were recovering in the hospital after a large tree fell on top of a vehicle on Fitchburg Road around 7 a.m. Monday, April 13. "The crash was caused by a random act of ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Neumora Therapeutics, Inc. (NASDAQ:NMRA) is featured in our list of the best penny stocks set to explode. As of April 8, 2026, analyst sentiment toward Neumora Therapeutics, Inc. (NASDAQ:NMRA) remains ...

What is the current share price of Neumora Therapeutics (NMRA)? Neumora Therapeutics's (NMRA) current share price is $2.13. This constitutes a price movement of 10.94% when compared to the share price ...

Neumora Therapeutics Inc (NASDAQ:NMRA) is among the best NASDAQ penny stocks to buy according to analysts. Presenting at the Guggenheim Emerging Outlook: Biotech Summit 2026 on February 11, Neumora ...

(RTTNews) - Neumora Therapeutics, Inc. (NMRA) has entered 2026 with momentum, announcing positive Phase 1b results for its lead candidate NMRA-511 in Alzheimer's disease agitation, along with a ...

Serious questions have been raised over Sri Lanka’s drug regulatory system following revelations that the National Medicines Regulatory Authority’s (NMRA) quality control laboratory is not accredited ...

RBC Capital Markets upgraded Neumora Therapeutics, Inc. (NASDAQ: NMRA) from Sector Perform to Outperform, with an increased price forecast from $4 to $7. The company is evolving beyond neurology and ...